Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Biocardia Inc (BCDA)

Biocardia Inc (BCDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Biocardia Inc 320 Soquel Way Sunnyvale CA 94085 USA

www.biocardia.com Employees: 20 P: 650-226-0120 F: 650-631-3731

Sector:

Medical

Description:

BioCardia Inc. is engaged in developing regenerative biologic therapies to treat cardiovascular disease. The company's product candidate consists of CardiAMP(TM), CardiALLO(TM) and Helix Biotherapeutic Delivery System(TM) in clinical development stage. BioCardia Inc. is headquartered in San Carlos, California.

Key Statistics

Overview:

Market Capitalization, $K 15,601
Enterprise Value, $K 13,231
Shares Outstanding, K 10,613
Annual Sales, $ 60 K
Annual Net Income, $ -7,950 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -1,480 K
EBIT, $ -8,590 K
EBITDA, $ -8,520 K
60-Month Beta 0.67
% of Insider Shareholders 17.40%
% of Institutional Shareholders 20.57%
Float, K 8,766
% Float 82.60%
Short Volume Ratio 0.14

Growth:

1-Year Return -36.57%
3-Year Return -94.34%
5-Year Return -96.52%
5-Year Revenue Growth -91.55%
5-Year Earnings Growth 92.59%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.24 on 11/12/25
Next Earnings Date N/A
Earnings Per Share ttm -1.48
EPS Growth vs. Prev Qtr 40.00%
EPS Growth vs. Prev Year 60.66%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 05/30/24

BCDA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -241.81%
Profit Margin % -13,250.00%
Debt/Equity 0.00
Price/Sales 259.84
Price/Cash Flow N/A
Price/Book 5.74
Book Value/Share 0.25
Interest Coverage -1.17
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar